Comment to FDA: World Health Organization ECDD Report Addressing the Review Status of Kratom and Its Alkaloids (Docket No. FDA-2022-N-0105)
Categories:
Dietary Ingredients & Supplements, Position Papers
Henningfield JE, Huestis MA, Grundmann O, Swogger MT, Prozialeck WC, Garcia-Romeu A, McCurdy CR.
This is a collaborative comment of concerned scientists regarding the WHO ECDD report addressing the review status of kratom and its alkaloids.
